During the past decade, Shanahan Rheumatology & Immunology, PLLC conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 12 clinical trials were completed, i.e. on average, 171.4% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Shanahan Rheumatology & Immunology, PLLC" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Actelion" with 1 trials sponsored and "Horizon Pharma Rheumatology LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Shanahan Rheumatology & Immunology, PLLC" are "Rheumatoid Arthritis" (3 trials), "Lupus Erythematosus, Systemic" (2 trials), "Spondyloarthritis" (2 trials), "Axial Spondyloarthritis" (1 trials) and "Refractory Chronic Gout" (1 trials). Many other conditions were trialed in "Shanahan Rheumatology & Immunology, PLLC" in a lesser frequency.

Most popular intervention types in "Shanahan Rheumatology & Immunology, PLLC" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ixekizumab" (3 trials), "GDC-0853" (2 trials), "Adalimumab" (1 trials) and "Etanercept" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shanahan Rheumatology & Immunology, PLLC" are 12 trials for "All" genders.

Currently, there are NaN active trials in "Shanahan Rheumatology & Immunology, PLLC". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Shanahan Rheumatology & Immunology, PLLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Shanahan Rheumatology & Immunology, PLLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".